These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 21960689

  • 1. Impact of EGFR genetic variants on glioma risk and patient outcome.
    Costa BM, Viana-Pereira M, Fernandes R, Costa S, Linhares P, Vaz R, Pinheiro C, Lima J, Soares P, Silva A, Pardal F, Amorim J, Nabiço R, Almeida R, Alegria C, Pires MM, Pinheiro C, Carvalho E, Oliveira P, Lopes JM, Reis RM.
    Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2610-7. PubMed ID: 21960689
    [Abstract] [Full Text] [Related]

  • 2. Association between functional EGF+61 polymorphism and glioma risk.
    Costa BM, Ferreira P, Costa S, Canedo P, Oliveira P, Silva A, Pardal F, Suriano G, Machado JC, Lopes JM, Reis RM.
    Clin Cancer Res; 2007 May 01; 13(9):2621-6. PubMed ID: 17473192
    [Abstract] [Full Text] [Related]

  • 3. A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter.
    Liu W, Innocenti F, Wu MH, Desai AA, Dolan ME, Cook EH, Ratain MJ.
    Cancer Res; 2005 Jan 01; 65(1):46-53. PubMed ID: 15665278
    [Abstract] [Full Text] [Related]

  • 4. EGFR gene polymorphisms -216G>T and -191C>A are risk markers for gastric cancer in Mexican population.
    Torres-Jasso JH, Marín ME, Santiago-Luna E, Leoner JC, Torres J, Magaña-Torres MT, Perea FJ, Ibarra B, Sánchez-López JY.
    Genet Mol Res; 2015 Mar 13; 14(1):1802-7. PubMed ID: 25867325
    [Abstract] [Full Text] [Related]

  • 5. CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphism.
    Nie Q, Yang XN, An SJ, Zhang XC, Yang JJ, Zhong WZ, Liao RQ, Chen ZH, Su J, Xie Z, Wu YL.
    Eur J Cancer; 2011 Sep 13; 47(13):1962-70. PubMed ID: 21616658
    [Abstract] [Full Text] [Related]

  • 6. EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) POLYMORPHIC VARIATIONS (-216G/T & -191 C/A) POSE A HIGH RISK TO PATIENTS WITH MALIGNANT GLIOMA.
    Zahoor W, Pandith AA, Nisar S, Qasim I, Surana M, Ganie FA, Manzoor U, Arif SH, Rasool SUA, Lateef A, Shah P, Bhat RA.
    Exp Oncol; 2023 Oct 11; 45(2):203-210. PubMed ID: 37824771
    [Abstract] [Full Text] [Related]

  • 7. Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer.
    Press OA, Zhang W, Gordon MA, Yang D, Lurje G, Iqbal S, El-Khoueiry A, Lenz HJ.
    Cancer Res; 2008 Apr 15; 68(8):3037-42. PubMed ID: 18413774
    [Abstract] [Full Text] [Related]

  • 8. Relationship of EGFR mutations, expression, amplification, and polymorphisms to epidermal growth factor receptor inhibitors in the NCI60 cell lines.
    Liu W, Wu X, Zhang W, Montenegro RC, Fackenthal DL, Spitz JA, Huff LM, Innocenti F, Das S, Cook EH, Cox NJ, Bates SE, Ratain MJ.
    Clin Cancer Res; 2007 Nov 15; 13(22 Pt 1):6788-95. PubMed ID: 18006781
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas.
    Lima-Ramos V, Pacheco-Figueiredo L, Costa S, Pardal F, Silva A, Amorim J, Lopes JM, Reis RM.
    Cancer Genet Cytogenet; 2008 Jan 01; 180(1):14-9. PubMed ID: 18068527
    [Abstract] [Full Text] [Related]

  • 11. Genetic polymorphisms of EGF 5'-UTR and NAT2 857G/A associated with glioma in a case control study of Malaysian patients.
    Muthusamy KA, Lian LH, Vairavan N, Chua KH, Waran V.
    Genet Mol Res; 2012 Aug 29; 11(3):2939-45. PubMed ID: 22782629
    [Abstract] [Full Text] [Related]

  • 12. Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas.
    Trizna Z, de Andrade M, Kyritsis AP, Briggs K, Levin VA, Bruner JM, Wei Q, Bondy ML.
    Cancer Epidemiol Biomarkers Prev; 1998 Jun 29; 7(6):553-5. PubMed ID: 9641501
    [Abstract] [Full Text] [Related]

  • 13. Allergy-related polymorphisms influence glioma status and serum IgE levels.
    Wiemels JL, Wiencke JK, Kelsey KT, Moghadassi M, Rice T, Urayama KY, Miike R, Wrensch M.
    Cancer Epidemiol Biomarkers Prev; 2007 Jun 29; 16(6):1229-35. PubMed ID: 17548690
    [Abstract] [Full Text] [Related]

  • 14. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
    Dehais C, Laigle-Donadey F, Marie Y, Kujas M, Lejeune J, Benouaich-Amiel A, Pedretti M, Polivka M, Xuan KH, Thillet J, Delattre JY, Sanson M.
    Cancer; 2006 Oct 15; 107(8):1891-7. PubMed ID: 16986124
    [Abstract] [Full Text] [Related]

  • 15. Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation.
    Zhang W, Park DJ, Lu B, Yang DY, Gordon M, Groshen S, Yun J, Press OA, Vallböhmer D, Rhodes K, Lenz HJ.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):600-5. PubMed ID: 15701846
    [Abstract] [Full Text] [Related]

  • 16. Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood.
    Bredel M, Pollack IF, Hamilton RL, James CD.
    Clin Cancer Res; 1999 Jul 15; 5(7):1786-92. PubMed ID: 10430083
    [Abstract] [Full Text] [Related]

  • 17. Analysis of EGFR overexpression, EGFR gene amplification and the EGFRvIII mutation in Portuguese high-grade gliomas.
    Viana-Pereira M, Lopes JM, Little S, Milanezi F, Basto D, Pardal F, Jones C, Reis RM.
    Anticancer Res; 2008 Jul 15; 28(2A):913-20. PubMed ID: 18507036
    [Abstract] [Full Text] [Related]

  • 18. Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients.
    Bandrés E, Barricarte R, Cantero C, Honorato B, Malumbres R, Zárate R, Alcalde J, García-Foncillas J.
    Oral Oncol; 2007 Aug 15; 43(7):713-9. PubMed ID: 17112774
    [Abstract] [Full Text] [Related]

  • 19. Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival.
    Wrensch M, Wiencke JK, Wiemels J, Miike R, Patoka J, Moghadassi M, McMillan A, Kelsey KT, Aldape K, Lamborn KR, Parsa AT, Sison JD, Prados MD.
    Cancer Res; 2006 Apr 15; 66(8):4531-41. PubMed ID: 16618782
    [Abstract] [Full Text] [Related]

  • 20. Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma.
    Liu Y, Zhang H, Zhou K, Chen L, Xu Z, Zhong Y, Liu H, Li R, Shugart YY, Wei Q, Jin L, Huang F, Lu D, Zhou L.
    Carcinogenesis; 2007 Sep 15; 28(9):1906-13. PubMed ID: 17389609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.